BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 135638)

  • 1. Reactivity of lymphocytes from primary neoplasms of lymphoid tissues.
    Twomey JJ; Laughter AH; Lazar S; Douglass CC
    Cancer; 1976 Aug; 38(2):740-7. PubMed ID: 135638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lymphocyte culture in the presence of phytohemagglutinins in Hodgkin's disease].
    Ferrari S; Foggi CM; Serafini NA
    Ann Ist Carlo Forlanini; 1968; 28(3):292-309. PubMed ID: 4903142
    [No Abstract]   [Full Text] [Related]  

  • 3. [Reactivity of the lymphocytes of lymph nodes in cases of malignant lymphoma to plant agglutinin].
    Stramignoni A; Navone R; Meriggi E
    Boll Soc Ital Biol Sper; 1969 Feb; 45(3):194-6. PubMed ID: 4899663
    [No Abstract]   [Full Text] [Related]  

  • 4. Mixed lymphocyte culture stimulatory and responding capacity of lymphocytes from patients with lymphoproliferative diseases.
    Rühl H; Vogt W; Bochert G; Schmidt S; Moelle R; Schaoua H
    Clin Exp Immunol; 1975 Jan; 19(1):55-65. PubMed ID: 128426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface markers and functional properties of non-Hodgkin's lymphoma cells in relation to histology.
    Bom-Van Noorloos AA; Splinter TA; van Heerde P; van Beek AA; Melief CJ
    Cancer; 1978 Oct; 42(4):1804-17. PubMed ID: 152144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte surface characteristics in malignant lymphoma.
    Aisenberg AC; Long JC
    Am J Med; 1975 Mar; 58(3):300-6. PubMed ID: 1090157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of immunoglobulin production by tumor cells in non-Hodgkin's and Hodgkin's malignant lymphomas and its significance for their classification.
    Stein H; Papadimitriou CS; Bouman H; Lennert K; Fuchs J
    Recent Results Cancer Res; 1978; 64():158-75. PubMed ID: 366694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hodgkin's disease. An immunodepleting and immunosuppressive disorder.
    Twomey JJ; Laughter AH; Farrow S; Douglass CC
    J Clin Invest; 1975 Aug; 56(2):467-75. PubMed ID: 125290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Culture of peripheral lymphocytes in chronic malignant lymphoadenopathies].
    Giraudo Conesa LC; Braun M; Bachmann AE; Pavlovsky A
    Prensa Med Argent; 1971 Aug; 58(23):1160-2. PubMed ID: 4940640
    [No Abstract]   [Full Text] [Related]  

  • 10. Depressed in vitro peripheral blood lymphocyte response to mitogens in cancer patients: the role of suppressor cells.
    Zembala M; Mytar B; Popiela T; Asherson GL
    Int J Cancer; 1977 May; 19(5):605-13. PubMed ID: 301122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte transformation in diseases of lymphoid tissue.
    Pentycross CR
    Proc R Soc Med; 1970 Apr; 63(4):355-7. PubMed ID: 4909839
    [No Abstract]   [Full Text] [Related]  

  • 12. Distribution of lymphocytes with interleukin-2 receptors (TAC antigens) in reactive lymphoproliferative processes, Hodgkin's disease, and non-Hodgkin's lymphomas. An immunohistologic study of 300 cases.
    Sheibani K; Winberg CD; van de Velde S; Blayney DW; Rappaport H
    Am J Pathol; 1987 Apr; 127(1):27-37. PubMed ID: 3105322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic abnormalities in patients with malignant lymphoproliferative diseases.
    Hunter CP; Tannenbaum H; Churchill WH; Moloney WC; Schur PH
    J Natl Cancer Inst; 1977 May; 58(5):1185-90. PubMed ID: 323504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro proliferative response of chronic lymphocytic leukemia.
    Neri A; Paciucci PA; Nobile F; Brugiatelli M; Camba L; Comis M; Iacopino P; Trapani Lombardo V
    Ric Clin Lab; 1977; 7(2):124-35. PubMed ID: 144313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell migration inhibition in human lymphomas using lymph node and cell line antigens.
    Braun M; Sen L; Bachmann AE; Pavlovsky A
    Blood; 1972 Mar; 39(3):368-76. PubMed ID: 4501089
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunologic and cytochemical cell markers in non-Hodgkin's lymphomas.
    Davey FR; Goldberg J; Stockman J; Gottlieb AJ
    Lab Invest; 1976 Nov; 35(5):430-8. PubMed ID: 792563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood B and T lymphocytes and in vitro cellular immune reactivity in untreated human malignant lymphomas and other malignant tumors.
    Heier HE; Klepp R; Gundersen S; Godal T; Normann T
    Scand J Haematol; 1977 Feb; 18(2):137-48. PubMed ID: 138931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of immunologic reactivity of lymphocytes from patients with chronic lymphocytic leukemia in various clinical conditions.
    Traczyk Z; Cieśluk S; Litwin J; Arczyńska E
    Arch Immunol Ther Exp (Warsz); 1975; 23(5):589-96. PubMed ID: 766725
    [No Abstract]   [Full Text] [Related]  

  • 19. [PRIMARY TUMORS OF THE LYMPH NODE AND THEIR EVALUATION ACCORDING TO BIOPSY MATERIAL].
    LUKASZEWSKI B
    Med Dosw; 1964; 27():119-70. PubMed ID: 14216819
    [No Abstract]   [Full Text] [Related]  

  • 20. [Blastic lymphocyte transformation caused by phytohemagglutinin in patients with lymphoproliferative diseases].
    Mantovani G; Petrini MT; Tognella S; Grifoni V
    Boll Soc Ital Biol Sper; 1972 Jul; 48(14):381-5. PubMed ID: 4628299
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.